The coronavirus could help pharma reset its reputation in Washington

  • STAT | by: Nicholas Florko |
  • 03/03/2020 12:00 AM
The coronavirus could help pharma reset its reputation in Washington
BIO says it has more than 20 companies pursuing coronavirus vaccines, therapeutics, or other products. Members like Moderna Therapeutics and Inovio are in the early stages of developing their own vaccines.

Drug industry critics, however, are unlikely to be impressed by pharma’s goodwill. Already, Democrats are insisting that drug makers should make any coronavirus treatment affordable. And the advocacy group Public Citizen has already criticized the drug industry for neglecting coronaviruses and vaccines more generally for more lucrative projects.

It’s also still too early to tell too whether Trump will be wooed by drug makers’ vaccine efforts and abandon his tough talk toward pharma, but drug industry defenders say it’s worth a shot.

“In a political season, telling politicians to put down really potent but incorrect and dangerous talking points may or may not be a fantasy,” said Peter Pitts, president of Center for Medicine in the Public Interest, which receives drug industry funding. “But it’s a battle worth fighting.”

 
Sign Up for Our Email Newsletter

RECENT NEWS

CMS comments on IRA Implementation
  • CMPI
  • 05/15/2023 12:00 AM

CMS comments on IRA Implementation

Allowing pharmacy benefit managers to continue with business-as-usual makes it impossible to build a health care ecosyste...  Read more

With 340B Ruling, Corrupt Hospitals Get What They Deserve

With 340B Ruling, Corrupt Hospitals Get What They Deserve

The runaway bureaucratic expansion of 340B must stop, and this court ruling is an important step. ...  Read more

Abortion ruling adds to growing GOP discontent with FDA

Abortion ruling adds to growing GOP discontent with FDA

The battle over the drug mifepristone comes after a tough stretch for the FDA: Controversy around the infant formula shor...  Read more

DRUGWONKS BLOG